Top Markets
Coin of the day
Ainos, Inc. Ainos, Inc.

Ainos, Inc.

AIMD
Rang in Aktien #32150
Ainos, Inc. operates as a healthcare technology company, specializing in... Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic developments include a COVID-19 nucleic acid test and point-of-care testing for volatile organic compounds. Furthermore, the company is progressing with Very Low-Dose Oral Interferon Alpha, an oral formulation engineered to leverage the wide therapeutic applications of IFN-a, and is actively developing a Synthetic RNA (sRNA) technology platform in Taiwan. Established in 1984, this San Diego, California-based firm was formerly known as Amarillo Biosciences, Inc. until its rebranding to Ainos, Inc. in May 2021.
Aktienkurs
$1.49
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$10.94M
Veränderung (1 Tag)
4.58%
Veränderung (1 Jahr)
-55.67%
Land
US
Handel Ainos, Inc. (AIMD)

Kategorie

Aktien-Split-Historie für Ainos, Inc. (AIMD)
Die Aktie Ainos, Inc. (Symbol: AIMD) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 18, 2026 statt.
Eine AIMD-Aktie, die vor dem Aug 18, 2026 gekauft wurde, entspricht heute 0 AIMD-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR